Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Neoplasms × Palliative Care × Clear all

Phase

Phase NA 11 Phase 2/3 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Motor Activity 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Carcinoma, Hepatocellular 1 Cancer Survivors 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 3 Standard of Care 3 Oxaliplatin 3 Melatonin 3 Gemcitabine 3 Fluorouracil 3 Drug Therapy 3 Capecitabine 3 pertuzumab 2 gamma-Globulins 2 cobimetinib 2 Water 2 Vemurafenib 2 Trastuzumab 2 Sirolimus 2 Saline Solution 2 Methylphenidate 2 Lidocaine 2 Leucovorin 2 Immunoglobulins, Intravenous 2 Docetaxel 2 Dexmedetomidine 2 Ciprofloxacin 2 vedolizumab 1 valrubicin 1 trametinib 1 sotrovimab 1 sintilimab 1 relatlimab 1 racemetyrosine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07408128 2026-02-13

P4E RCT

McMaster University

Phase 2/3 Not yet recruiting

Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡